Search Bar & Filters
Found 43 Actively Recruiting clinical trials
Actively Recruiting
Cognitive impairment related to dementia is often missed in primary care, especially among older adults from minority and socio-economically disadvantaged populations. Researchers are evaluating the 5-Cog brief cognitive assessment, a quick, simple, and standardized tool that takes less than 5 minutes and addresses cultural and logistical barriers. This pragmatic cluster-randomized trial aims to test whether the 5-Cog paradigm improves detection of new cases of cognitive impairment and dementia care in older adults with cognitive concerns. The study involves 22 primary care clinics in Bronx and Indiana, enrolling about 6,600 patients aged 65 and older who report cognitive concerns. Participants receive either the 5-Cog battery combined with a clinical decision-making tool or enhanced usual care, which includes cognitive concern screening. The 5-Cog battery includes tests like Picture Memory Impairment Screen, Motoric Cognitive Risk Syndrome diagnosis, and Symbol Match. Primary care physicians receive results and decision support but use their clinical judgment in care decisions. Participants undergo cognitive concern screening before their appointments. Researchers will review new cognitive impairment diagnoses and improvements in dementia care within 90 days after the primary care visit using electronic medical records. Additional evaluations include tests for reversible causes, medication changes, specialist referrals, and social support. The study also examines the 5-Cog paradigms implementation and cost-effectiveness, focusing on populations facing health disparities. Total participation duration varies by patient and clinic schedule.
Actively Recruiting
Researchers are evaluating the Green Activity Program designed for people living with memory challenges and their study partners. The program includes outdoor nature activities such as dog walking, hiking, yoga, and gardening, aiming to help participants stay active and improve their health and well-being. This feasibility study focuses on whether participants can complete and enjoy the program, supporting their participation in nature activities. The study involves a single group of 40 pairs dyads consisting of individuals with memory challenges and their study partners. Over 12 weeks, participants engage in 4 to 8 virtual or phone sessions lasting 30 to 90 minutes each, plus 2 additional check-ins of 15 to 30 minutes. Outdoor activity professionals also participate by evaluating sites for safety and accessibility, receiving dementia training, and learning strategies to tailor activities and provide behavioral support. Participants complete evaluations before and after the 12-week program, including surveys, brief phone interviews, and physical activity and health assessments. Researchers measure feasibility, acceptability, behavior change, physical activity, well-being, social participation, depression, cognitive function, and other health-related outcomes. Feedback from study partners and outdoor professionals is also collected. The total study duration for participants may last up to one year to include all evaluations and follow-ups.
Actively Recruiting
This research aims to compare two approaches for treating previously untreated amblyopia in children aged 3 to under 13 years. It evaluates whether using glasses and patching at the same time leads to similar improvements in vision as first using glasses alone, followed by patching only if needed. The trial focuses on children with amblyopia caused by differences in eye alignment or prescription errors. Children will be assigned randomly to one of two treatment groups one group will wear glasses full-time and add patching for 2 hours daily only if there is no improvement after glasses alone the other group will wear glasses and patch the weaker eye for 2 hours daily at the same time from the start. Vision tests will be done at baseline and follow-up visits every 8 weeks for up to 56 weeks. Participants will have their distance visual acuity measured with trial frames before and after getting their glasses to confirm eligibility. During the study, vision will be monitored to classify improvement or stability, guiding whether patching is needed in the sequential group. Outcomes include changes in vision clarity after 56 weeks and quality-of-life assessments. Regular visits help track progress and safety until study completion.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating whether replacing sugary sodas with unsweetened, flavored sparkling waters, progressively sugar-reduced sodas, or plain water can reduce added sugar intake and improve health in BlackAfrican American and Latine adolescents with obesity who prefer sweet-tasting beverages. The study focuses on adolescents aged 12 to 18 who have a strong liking for sweet beverages and consume sugary sodas regularly. The trial aims to understand if changing beverage preferences leads to better diet quality and cardiometabolic health. Participants will be randomly assigned to one of three groups replacing sugary sodas with flavored unsweetened sparkling water, replacing sodas with beverages that gradually reduce sugar content over four weeks ending with unsweetened sparkling water, or replacing sodas with plain still water as a control. The intervention lasts for four weeks, during which participants will replace all sugary sodas with their assigned study beverages. During the 8-week study period, participants will complete taste tests at baseline, week 2, week 4, and week 8 to assess their liking and perception of sweetness. Dietary recalls, body measurements including height, weight, and waist circumference, blood pressure readings, and blood samples measuring fasting glucose, insulin, and triglycerides will be collected at baseline, week 4, and week 8. Researchers will monitor compliance with beverage consumption and evaluate changes in sugar liking, diet quality, and cardiometabolic markers, including serum triglycerides and insulin resistance.
Actively Recruiting
Healthy Volunteer
Researchers are examining whether an online weight loss program that emphasizes specific goalsconsuming at least 30 grams of protein per meal, 30 grams of fiber daily, and 30 minutes of daily exercise the 30-30-30 plancan improve weight loss and other health markers compared to a standard online weight loss program. This randomized, controlled trial focuses on adults aged 18 to 69 with overweight or obesity. The study aims to assess effects on body weight, body composition, and cardiometabolic risk factors. Participants are randomly assigned to one of two groups a standard interactive online weight loss program or the 30-30-30 PFE intervention, which adds specific dietary and exercise goals. Both programs are delivered online and adapted from the Rx Weight Loss program. The study intervention lasts for 24 weeks, during which participants engage with the online programs and work toward their assigned goals. During the 24-week study, participants will be monitored through various assessments including body weight measurements at weeks 0, 8, 16, and 24 waist circumference body composition fasting blood tests measuring lipoprotein lipids, glycemia markers, and inflammation biomarkers and resting blood pressure. Participants are expected to attend virtual meetings and adhere to dietary and exercise plans. The study evaluates these measures to understand the impact of the programs on weight and health markers.
Actively Recruiting
Researchers are evaluating two FDA-approved eye drops, netarsudil Rhopressa and timolol, to see how well they protect nerve cells in the eyes of adults with open-angle glaucoma. This condition causes loss of retinal ganglion cells, which are important for vision. The study aims to find out if Rhopressa slows down or prevents this cell loss better than timolol while both lower eye pressure. This research is a Phase 4, randomized, double-masked crossover study. Participants will use both medications during the study, each for six months in a random order. One group will start with Rhopressa once daily in the evening for six months, then switch to timolol twice daily for the next six months. The other group will do the opposite. Eye exams and measurements will be taken at baseline, six months, and twelve months, including advanced imaging with adaptive optics optical coherence tomography AO-OCT to count nerve cells, standard OCT, tonometry to measure eye pressure, and visual field tests. Participants will attend six visits over twelve months for eye examinations and imaging. Researchers will track changes in nerve cell density, counts, and thickness of the ganglion cell layer to compare the effects of both eye drops. Safety and tolerance will also be monitored. The study helps understand how these treatments influence nerve cell protection in glaucoma over one year.
Actively Recruiting
Researchers are evaluating the effects of muvalaplin in reducing the risk of major cardiovascular events in adults with elevated lipoproteina levels who either have cardiovascular disease or are at risk for a heart attack or stroke. This Phase 3, randomized, double-blind, placebo-controlled study focuses on adults with high lipoproteina and a history or risk of atherosclerotic cardiovascular events. The study aims to better understand if muvalaplin can lower the occurrence of serious heart-related problems. Participants will be randomly assigned to receive either muvalaplin or a placebo, both taken orally. The study compares these two groups over about 5.25 years to assess the impact of muvalaplin on major adverse cardiac events. The research includes ongoing monitoring of lipoproteina levels and other cardiovascular outcomes throughout this period. During the study, participants will undergo regular assessments including measuring changes in lipoproteina, tracking the time to occurrence of major cardiovascular events, and monitoring overall health outcomes. Researchers will collect data on healthcare resource usage and drug levels in the body. The long-term follow-up allows for thorough evaluation of muvalaplins effects on heart health and safety over more than five years.
Actively Recruiting
Healthy Volunteer
Researchers are studying myopia and its progression in children aged 7 to 14 years. The trial aims to understand which areas of spectacle lenses children use when viewing, regardless of the task. This study evaluates different spectacle lens designs intended to correct myopia and potentially slow its progression in juvenile patients. Participants will use either a novel spectacle lens design or a standard single vision, impact-resistant spectacle lens. The study compares these two types of lenses worn by children to assess viewing behavior. The trial uses a randomized crossover design, where children will experience both lens types during the study. Children will be monitored over a 2-month period to measure gaze location while wearing the myopia control spectacles. Researchers will also assess activity levels through surveys or observation and record pupil size. Participants must attend scheduled visits and follow instructions to support data collection on how different lens designs may influence viewing behavior and myopia control.
Actively Recruiting
Researchers are evaluating the measurements of ocular lipid layer thickness LLT taken by three commonly used clinical devices to compare their agreement and consistency. The study also aims to find which devices LLT measurements best correlate with established clinical indicators of dry eye disease severity. Participants with dry eye disease will have their lipid layer thickness measured using three different devices LipiView, Omnicad, and Bruder Ocular Surface Analyzer. These measurements will be taken during a single visit in a random order to ensure unbiased comparison. During the study visit, participants will undergo LLT measurement with all three devices. Researchers will analyze the measurements and compare them to clinical assessments of dry eye severity. The main outcome is the LLT measurement at baseline, alongside the correlation with clinical dry eye indicators. The study participation involves a single visit and does not include any treatment or long-term follow-up.
Actively Recruiting
Healthy Volunteer
Researchers are investigating whether the COVID-19 pandemic has impacted peoples physical activity, fitness, blood pressure, sleep, and mental stress to understand its long-term effects on health. The study looks at how prior COVID-19 severity or post-acute sequelae of SARS-CoV-2 infection PASC might be linked to changes in cardiovascular health and overall wellness. Participants will take part in two visits at the Neurovascular Physiology Laboratory, with detailed data collected to explore these health aspects. During the first visit, participants complete questionnaires about their health behaviors, sleep, stress, diet, and mental well-being. They will then track their sleep and physical activity with wearable devices for about 14 days, record their diet for at least 3 days, and measure blood pressure and urine for 24 hours. The second visit involves returning devices and undergoing various tests, including body composition scans, cardiovascular health measurements, a fitness test on a stationary bike, blood and urine sample collection, and a cold-water hand test to assess nervous system response to stress. Participants involvement includes completing questionnaires, wearing tracking devices, and attending two study visits totaling about 6 hours. Researchers will measure blood pressure, sleep quality, diet, cardiovascular fitness, immune markers, and body composition. Safety is carefully monitored during exercise and testing. The primary outcomes focus on blood pressure measurements, while secondary outcomes include sleep duration and quality, and diet quality. The study aims to provide valuable insights into how COVID-19 affects long-term health.
1-10 of 43
1